Cosentyx Drug Market to Reach USD 4,500 Million by 2035, Registering a CAGR of 7.1%
The global market for Cosentyx is witnessing strong growth as demand for advanced biologic therapies continues to rise across the healthcare sector. Cosentyx, a leading immunology drug developed by Novartis, has become a key treatment option for several chronic inflammatory diseases, including psoriasis, … Read more